These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 341929)

  • 21. [Effects of new beta receptor blocking agent Acebutolol in patients with essential, renal, and broderline hypertension].
    Werning C
    Med Welt; 1977 Sep; 28(39):1564-6. PubMed ID: 22016
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hemodynamic effects of intravenous acebutolol in the acute phase of myocardial infarction].
    Metzger JP; Montgermont P; N'Koua JL; Baubion N; Adams C; Meilhac B; Le Pailleur C; Vacheron A
    Ann Cardiol Angeiol (Paris); 1985 Jun; 34(6):377-80. PubMed ID: 4026163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
    Collett JT; Hendrickson JA; Chew CY; Shah PM; Laddu AR; Singh BN
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):473-8. PubMed ID: 6117519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Change, by nicergoline, of the hemodynamic effects of acebutolol in healthy subjects].
    Moore N; Chretien P; Saligaut C; Daoust M; Boismare F
    Therapie; 1984; 39(2):103-8. PubMed ID: 6729761
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemodynamic effects of the intravenous form of acebutolol].
    Delaye J; Pourchaire J; Gonin A
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3239-43. PubMed ID: 1219631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro studies on the pharmacological properties of diacetolol, the major metabolite of acebutolol in man.
    Borchard U; Hafner D; Hirth C
    Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):4-17. PubMed ID: 2860878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemodynamic effects and effects on plasma renin activity of injectable acebutolol in arterial hypertension].
    Lekieffre J; Carré A; Ginestet A; Dewailly P; Warembourg H
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3247-51. PubMed ID: 768906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acebutolol and oral surgery: plasma levels following a single oral dose.
    Fergusson NV; Dalgleish JG; Saunders DA
    Ann R Coll Surg Engl; 1985 Mar; 67(2):124-6. PubMed ID: 3883878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hypertension with single daily doses of acebutolol.
    Leary WP; Asmal AC; Williams PC; Marwick B
    S Afr Med J; 1978 Apr; 53(15):579-81. PubMed ID: 354042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of acebutolol (M and B 17803, R 21823) on central sympathetic structures].
    Daskalopoulos NT; Schmitt H
    Therapie; 1975; 30(6):843-54. PubMed ID: 1232684
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
    Reim HG; Wagner W
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):238-43. PubMed ID: 4008112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acebutolol in angina pectoris: objective assessment using graded treadmill testing.
    Kimchi A; Gotsman MS; Lewis BS
    Isr J Med Sci; 1978 Sep; 14(9):941-7. PubMed ID: 363642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels and electrophysiological effects of acebutolol (M & B 17.803) in the dog heart in situ.
    Amlie JP; Lessum S; Collins RF; Landmark K
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):378-88. PubMed ID: 190859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differences in hemodynamic effects of the cardioselective beta-adrenoblocker acebutolol and non-selective beta-adrenoblocker propranolol in long-term antihypertensive therapy].
    Metelitsa VI; Duda SG; Ostrovskaia TP; Malysheva NV; Lerman OV; Shastun RS; Manoshkina EM; Piotrovskiĭ VK; Rumiantsev DO; Belolipetskaia VG
    Kardiologiia; 1993; 33(4):32-8. PubMed ID: 7933789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of the alpha 1-receptor blocker prazosin and the beta 1-receptor blocker acebutolol and their combination on blood pressure and pressure rate product. Ergometric studies of hypertensive patients].
    Franz IW
    Z Kardiol; 1984 Jan; 73(1):21-8. PubMed ID: 6367245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of the cardiovascular effects of acebutolol (Sectral) in the postoperative period in hypertensive patients treated with beta blockers].
    Schoeffler P; Ferrier C; Mirault F; Dieng PN; Derbal C; Aigouy L
    Cah Anesthesiol; 1987; 35(2):93-7. PubMed ID: 3607585
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemodynamic effects of intravenous diltiazem after immediate coronary revascularization].
    Bukowski JG; Mattachione A; Moreau X; Corbeau JJ; Cottineau C; Jacob JP
    Cah Anesthesiol; 1995; 43(2):195-8. PubMed ID: 7671087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intraoperative assessment of the effects of nitroglycerin on myocardial contraction in patients with ischemic heart disease during aortocoronary bypass].
    Seleznev MN; Flerov EV; Iakovlev VF
    Anesteziol Reanimatol; 1995; (2):23-5. PubMed ID: 7645768
    [No Abstract]   [Full Text] [Related]  

  • 39. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemodynamic effects and effects on the renin-angiotensin-aldosterone system of the combination of nifedipine and acebutolol in patients with essential hypertension].
    Novo S; Salerno L; Licata G; Pinto A; Avellone G; Davì G; Faldetta E; Strano A
    Boll Soc Ital Cardiol; 1981; 26(12):2413-26. PubMed ID: 7185412
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.